BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20618249)

  • 1. Should simple hysterectomy be added after chemo-radiation for stage IB2 and bulky IIA cervical carcinoma?
    Eitan R; Levavi H; Peled Y; Brenner R; Sabah G; Ben-Arie A; Dgani R; Fishman A; Sulkes A; Fenig E; Koren C
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):289-93. PubMed ID: 20618249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
    Kochbati L; Ben Ammar CN; Benna F; Hechiche M; Boussen H; Besbes M; Ben Abdallah M; Rahal K; Ben Ayed F; Ben Romdhane K; Maalej M
    Tunis Med; 2005 Mar; 83(3):146-9. PubMed ID: 15929442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
    Azria E; Morice P; Haie-Meder C; Thoury A; Pautier P; Lhomme C; Duvillard P; Castaigne D
    Ann Surg Oncol; 2005 Apr; 12(4):332-7. PubMed ID: 15827678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates.
    Decker MA; Burke JJ; Gallup DG; Silverio RW; Weems D; Duttenhaver J; Purcell D
    Am J Obstet Gynecol; 2004 Aug; 191(2):654-8; discussion 658-60. PubMed ID: 15343258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Large volume stage I and II epidermoid carcinoma of the uterine cervix treated with primary radiotherapy and surgery].
    Touboul E; Lefranc JP; Belkacémi Y; Rogel A; Deluen F; Blondon J; Housset M
    Contracept Fertil Sex; 1998 Sep; 26(9):674-85. PubMed ID: 9823696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma.
    Paley PJ; Goff BA; Minudri R; Greer BE; Tamimi HK; Koh WJ
    Gynecol Oncol; 2000 Mar; 76(3):373-9. PubMed ID: 10684713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
    Ijaz T; Eifel PJ; Burke T; Oswald MJ
    Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer.
    Cheewakriangkrai C; Srisomboon J; Chitapanarux I; Suprasert P; Phongnarisorn C; Siriaree S; Charoenkwan K
    J Med Assoc Thai; 2005 Oct; 88(10):1331-7. PubMed ID: 16519375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
    Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J
    J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.